Nitroaspirin
Nitroaspirin (NCX 4016) is a nitric oxide (NO) donor and a nitro-derivative of Aspirin, which combines with Nitroaspirin to inhibit cyclooxygenase. Nitroaspirin (NCX 4016) has antithrombotic and anti-platelet properties and acts as a direct and irreversible inhibitor of COX-1. Nitroaspirin (NCX 4016) causes significant induction of cell cycle arrest and apoptosis in Cisplatin-resistant human ovarian cancer cells via down-regulation of EGFR/PI3K/STAT3 signaling and modulation of Bcl-2 family proteins[1][2][3][4].
Product Specifications
CAS Number
175033-36-0
Product Name Alternative
NCX 4016
UNSPSC
12352005
Target
Apoptosis; COX
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nitroaspirin.html
Concentration
10mM
Purity
98.57
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
O=C(OC1=CC=CC(CO[N+]([O-])=O)=C1)C2=CC=CC=C2OC(C)=O
Molecular Formula
C16H13NO7
Molecular Weight
331.28
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
COX-1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD117 / c-Kit (Marker for Gastrointestinal Stromal Tumors) (KIT/2674), CF647 conjugate, 0.1mg/mL
